My watch list
my.bionity.com  
Login  

High-dose melphalan followed by ASCT has favorable safety and efficacy in selected patients with light chain deposition disease and light and heavy chain deposition disease

High-dose melphalan followed by ASCT has favorable safety and efficacy in selected patients with light chain deposition disease and light and heavy chain deposition disease

Bone Marrow Transplantation advance online publication, April 18, 2011. doi:10.1038/bmt.2011.87

Authors: D Telio, J Shepherd, D Forrest, L Zypchen, M Barnett, T Nevill & K W Song

Authors:   D Telio, J Shepherd, D Forrest, L Zypchen, M Barnett, T Nevill, K W Song
Journal:   Bone Marrow Transplantation
Year:   2011
DOI:   10.1038/bmt.2011.87
Publication date:   18-04-2011

Watchlist

This is where you can add this publication to your personal favourites.

Additional Information

Facts, background information, dossiers
More about Nature Publishing Group
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE